MedPath

SUperiority of Perineoplasty as concomitant surgical procedure during Pelvic Organ prolapse Repair: a comparative cohort Trial (SUPPORT)

Recruiting
Conditions
prolapse
10029903
Registration Number
NL-OMON51797
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
288
Inclusion Criteria

Patients >18 years indicated for vaginal POP surgery
Inlcusion criteria:
1. Female patient> 18 years of age
2. Complaints of pelvic organ prolapse
3. Indication for vaginal native tissue prolapse surgery (level I and/or level
II repair)
4.Genital hiatus (GH) according to POP-Q staging of >=4 cm and <=7 cm

Exclusion Criteria

1. Unable to understand the Dutch language
2. Pregnancy at baseline or intendancy to become pregnant during the study
period
3. Patients with previous surgery for POP (previous mid urethral sling
operation for stress urinary incontinence not excluded)
4. Unwilling to participate in the study and/or incapable of giving informed
consent

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary Outcome: Surgical success, which is a composite outcome defined as<br /><br>meeting the 3 following conditions: [1] *much improved* or *improved* in<br /><br>response to the patient global impression of improvement questionnaire, [2] no<br /><br>re-intervention performed in the same compartment within the first 12 months<br /><br>after index surgery, [3] no stage 2 or more POP in the operated compartment<br /><br>Secondary outcomes: Morbidity: complications and re-interventions due to<br /><br>complications</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes: Morbidity: complications and re-interventions due to<br /><br>complications, pain. Effectiveness: disease specific and general quality of<br /><br>life. Anatomical outcomes. Societal costs.</p><br>
© Copyright 2025. All Rights Reserved by MedPath